Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21).

      Cancer research
      Aged, Amino Acid Sequence, Base Sequence, Basic Helix-Loop-Helix Transcription Factors, Cells, Cultured, Chondrosarcoma, genetics, metabolism, Chromosome Banding, Chromosomes, Human, Pair 15, Chromosomes, Human, Pair 9, Cytoplasm, DNA-Binding Proteins, chemistry, Helix-Loop-Helix Motifs, Humans, Male, Molecular Sequence Data, Muscle Neoplasms, Nerve Tissue Proteins, Nuclear Proteins, Protein Binding, Protein Structure, Tertiary, Receptors, Steroid, Receptors, Thyroid Hormone, Reverse Transcriptase Polymerase Chain Reaction, Sequence Analysis, DNA, Transcription Factors, Translocation, Genetic

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Extraskeletal myxoid chondrosarcomas (EMCs) are characterized by recurrent t(9;22) or t(9;17) translocations resulting in fusions of the NH2-terminal transactivation domains of EWS or TAF2N to the entire TEC protein. We report here an EMC with a novel translocation t(9; 15)(q22;q21) and a third type of TEC-containing fusion gene. The chimeric transcript encodes a protein in which the first 108 amino acids of the NH2-terminus of the basic helix-loop-helix (bHLH) protein TCF12 is linked to the entire TEC protein. The translocation separates the NH2-terminal domain of TCF12 from the bHLH domain as well as from a potential leucine zipper domain located immediately downstream of the breakpoint. These results demonstrate that the NH2-terminal transactivation domains of EWS or TAF2N are not unique in their ability to convert the TEC protein into an oncogenically active fusion protein, and that they may be replaced by a domain from a bHLH protein that presumably endows the fusion protein with similar functions.

          Related collections

          Author and article information

          Comments

          Comment on this article